Global CGT CDMO Supply, Demand and Key Producers, 2023-2029

Page: 123

Published Date: 02 Jan 2024

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global CGT CDMO market size is expected to reach $ 17320 million by 2029, rising at a market growth of 23.0% CAGR during the forecast period (2023-2029).

Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.

CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.

This report studies the global CGT CDMO demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for CGT CDMO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of CGT CDMO that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global CGT CDMO total market, 2018-2029, (USD Million)
Global CGT CDMO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: CGT CDMO total market, key domestic companies and share, (USD Million)
Global CGT CDMO revenue by player and market share 2018-2023, (USD Million)
Global CGT CDMO total market by Type, CAGR, 2018-2029, (USD Million)
Global CGT CDMO total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global CGT CDMO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Catalent, Lonza, Thermo Fisher, ACG Biologics, WuXi AppTec, Charles River, Oxford Biomedica (OXB), Novartis and OBiO, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World CGT CDMO market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global CGT CDMO Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global CGT CDMO Market, Segmentation by Type
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA

Global CGT CDMO Market, Segmentation by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others

Companies Profiled:
Catalent
Lonza
Thermo Fisher
ACG Biologics
WuXi AppTec
Charles River
Oxford Biomedica (OXB)
Novartis
OBiO
GenScript
Pharmaron
Porton

Key Questions Answered
1. How big is the global CGT CDMO market?
2. What is the demand of the global CGT CDMO market?
3. What is the year over year growth of the global CGT CDMO market?
4. What is the total value of the global CGT CDMO market?
5. Who are the major players in the global CGT CDMO market?

Table of Contents

1 Supply Summary
    1.1 CGT CDMO Introduction
    1.2 World CGT CDMO Market Size & Forecast (2018 & 2022 & 2029)
    1.3 World CGT CDMO Total Market by Region (by Headquarter Location)
        1.3.1 World CGT CDMO Market Size by Region (2018-2029), (by Headquarter Location)
        1.3.2 United States CGT CDMO Market Size (2018-2029)
        1.3.3 China CGT CDMO Market Size (2018-2029)
        1.3.4 Europe CGT CDMO Market Size (2018-2029)
        1.3.5 Japan CGT CDMO Market Size (2018-2029)
        1.3.6 South Korea CGT CDMO Market Size (2018-2029)
        1.3.7 ASEAN CGT CDMO Market Size (2018-2029)
        1.3.8 India CGT CDMO Market Size (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 CGT CDMO Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 CGT CDMO Major Market Trends

2 Demand Summary
    2.1 World CGT CDMO Consumption Value (2018-2029)
    2.2 World CGT CDMO Consumption Value by Region
        2.2.1 World CGT CDMO Consumption Value by Region (2018-2023)
        2.2.2 World CGT CDMO Consumption Value Forecast by Region (2024-2029)
    2.3 United States CGT CDMO Consumption Value (2018-2029)
    2.4 China CGT CDMO Consumption Value (2018-2029)
    2.5 Europe CGT CDMO Consumption Value (2018-2029)
    2.6 Japan CGT CDMO Consumption Value (2018-2029)
    2.7 South Korea CGT CDMO Consumption Value (2018-2029)
    2.8 ASEAN CGT CDMO Consumption Value (2018-2029)
    2.9 India CGT CDMO Consumption Value (2018-2029)

3 World CGT CDMO Companies Competitive Analysis
    3.1 World CGT CDMO Revenue by Player (2018-2023)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global CGT CDMO Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for CGT CDMO in 2022
        3.2.3 Global Concentration Ratios (CR8) for CGT CDMO in 2022
    3.3 CGT CDMO Company Evaluation Quadrant
    3.4 CGT CDMO Market: Overall Company Footprint Analysis
        3.4.1 CGT CDMO Market: Region Footprint
        3.4.2 CGT CDMO Market: Company Product Type Footprint
        3.4.3 CGT CDMO Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: CGT CDMO Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: CGT CDMO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
        4.1.2 United States VS China: CGT CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States Based Companies VS China Based Companies: CGT CDMO Consumption Value Comparison
        4.2.1 United States VS China: CGT CDMO Consumption Value Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: CGT CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States Based CGT CDMO Companies and Market Share, 2018-2023
        4.3.1 United States Based CGT CDMO Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies CGT CDMO Revenue, (2018-2023)
    4.4 China Based Companies CGT CDMO Revenue and Market Share, 2018-2023
        4.4.1 China Based CGT CDMO Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies CGT CDMO Revenue, (2018-2023)
    4.5 Rest of World Based CGT CDMO Companies and Market Share, 2018-2023
        4.5.1 Rest of World Based CGT CDMO Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies CGT CDMO Revenue, (2018-2023)

5 Market Analysis by Type
    5.1 World CGT CDMO Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Immune Cells
        5.2.2 Stem Cells
        5.2.3 Viral Vectors
        5.2.4 Plasmid DNA
    5.3 Market Segment by Type
        5.3.1 World CGT CDMO Market Size by Type (2018-2023)
        5.3.2 World CGT CDMO Market Size by Type (2024-2029)
        5.3.3 World CGT CDMO Market Size Market Share by Type (2018-2029)

6 Market Analysis by Application
    6.1 World CGT CDMO Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Pharmaceutical and Biotechnology Companies
        6.2.2 Research and Academic Institutions
        6.2.3 Hospital
        6.2.4 Others
        6.2.5 Others
    6.3 Market Segment by Application
        6.3.1 World CGT CDMO Market Size by Application (2018-2023)
        6.3.2 World CGT CDMO Market Size by Application (2024-2029)
        6.3.3 World CGT CDMO Market Size by Application (2018-2029)

7 Company Profiles
    7.1 Catalent
        7.1.1 Catalent Details
        7.1.2 Catalent Major Business
        7.1.3 Catalent CGT CDMO Product and Services
        7.1.4 Catalent CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.1.5 Catalent Recent Developments/Updates
        7.1.6 Catalent Competitive Strengths & Weaknesses
    7.2 Lonza
        7.2.1 Lonza Details
        7.2.2 Lonza Major Business
        7.2.3 Lonza CGT CDMO Product and Services
        7.2.4 Lonza CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.2.5 Lonza Recent Developments/Updates
        7.2.6 Lonza Competitive Strengths & Weaknesses
    7.3 Thermo Fisher
        7.3.1 Thermo Fisher Details
        7.3.2 Thermo Fisher Major Business
        7.3.3 Thermo Fisher CGT CDMO Product and Services
        7.3.4 Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.3.5 Thermo Fisher Recent Developments/Updates
        7.3.6 Thermo Fisher Competitive Strengths & Weaknesses
    7.4 ACG Biologics
        7.4.1 ACG Biologics Details
        7.4.2 ACG Biologics Major Business
        7.4.3 ACG Biologics CGT CDMO Product and Services
        7.4.4 ACG Biologics CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.4.5 ACG Biologics Recent Developments/Updates
        7.4.6 ACG Biologics Competitive Strengths & Weaknesses
    7.5 WuXi AppTec
        7.5.1 WuXi AppTec Details
        7.5.2 WuXi AppTec Major Business
        7.5.3 WuXi AppTec CGT CDMO Product and Services
        7.5.4 WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.5.5 WuXi AppTec Recent Developments/Updates
        7.5.6 WuXi AppTec Competitive Strengths & Weaknesses
    7.6 Charles River
        7.6.1 Charles River Details
        7.6.2 Charles River Major Business
        7.6.3 Charles River CGT CDMO Product and Services
        7.6.4 Charles River CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.6.5 Charles River Recent Developments/Updates
        7.6.6 Charles River Competitive Strengths & Weaknesses
    7.7 Oxford Biomedica (OXB)
        7.7.1 Oxford Biomedica (OXB) Details
        7.7.2 Oxford Biomedica (OXB) Major Business
        7.7.3 Oxford Biomedica (OXB) CGT CDMO Product and Services
        7.7.4 Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.7.5 Oxford Biomedica (OXB) Recent Developments/Updates
        7.7.6 Oxford Biomedica (OXB) Competitive Strengths & Weaknesses
    7.8 Novartis
        7.8.1 Novartis Details
        7.8.2 Novartis Major Business
        7.8.3 Novartis CGT CDMO Product and Services
        7.8.4 Novartis CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.8.5 Novartis Recent Developments/Updates
        7.8.6 Novartis Competitive Strengths & Weaknesses
    7.9 OBiO
        7.9.1 OBiO Details
        7.9.2 OBiO Major Business
        7.9.3 OBiO CGT CDMO Product and Services
        7.9.4 OBiO CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.9.5 OBiO Recent Developments/Updates
        7.9.6 OBiO Competitive Strengths & Weaknesses
    7.10 GenScript
        7.10.1 GenScript Details
        7.10.2 GenScript Major Business
        7.10.3 GenScript CGT CDMO Product and Services
        7.10.4 GenScript CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.10.5 GenScript Recent Developments/Updates
        7.10.6 GenScript Competitive Strengths & Weaknesses
    7.11 Pharmaron
        7.11.1 Pharmaron Details
        7.11.2 Pharmaron Major Business
        7.11.3 Pharmaron CGT CDMO Product and Services
        7.11.4 Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.11.5 Pharmaron Recent Developments/Updates
        7.11.6 Pharmaron Competitive Strengths & Weaknesses
    7.12 Porton
        7.12.1 Porton Details
        7.12.2 Porton Major Business
        7.12.3 Porton CGT CDMO Product and Services
        7.12.4 Porton CGT CDMO Revenue, Gross Margin and Market Share (2018-2023)
        7.12.5 Porton Recent Developments/Updates
        7.12.6 Porton Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 CGT CDMO Industry Chain
    8.2 CGT CDMO Upstream Analysis
    8.3 CGT CDMO Midstream Analysis
    8.4 CGT CDMO Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World CGT CDMO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
    Table 2. World CGT CDMO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
    Table 3. World CGT CDMO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
    Table 4. World CGT CDMO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
    Table 5. World CGT CDMO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World CGT CDMO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
    Table 8. World CGT CDMO Consumption Value by Region (2018-2023) & (USD Million)
    Table 9. World CGT CDMO Consumption Value Forecast by Region (2024-2029) & (USD Million)
    Table 10. World CGT CDMO Revenue by Player (2018-2023) & (USD Million)
    Table 11. Revenue Market Share of Key CGT CDMO Players in 2022
    Table 12. World CGT CDMO Industry Rank of Major Player, Based on Revenue in 2022
    Table 13. Global CGT CDMO Company Evaluation Quadrant
    Table 14. Head Office of Key CGT CDMO Player
    Table 15. CGT CDMO Market: Company Product Type Footprint
    Table 16. CGT CDMO Market: Company Product Application Footprint
    Table 17. CGT CDMO Mergers & Acquisitions Activity
    Table 18. United States VS China CGT CDMO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 19. United States VS China CGT CDMO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 20. United States Based CGT CDMO Companies, Headquarters (States, Country)
    Table 21. United States Based Companies CGT CDMO Revenue, (2018-2023) & (USD Million)
    Table 22. United States Based Companies CGT CDMO Revenue Market Share (2018-2023)
    Table 23. China Based CGT CDMO Companies, Headquarters (Province, Country)
    Table 24. China Based Companies CGT CDMO Revenue, (2018-2023) & (USD Million)
    Table 25. China Based Companies CGT CDMO Revenue Market Share (2018-2023)
    Table 26. Rest of World Based CGT CDMO Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies CGT CDMO Revenue, (2018-2023) & (USD Million)
    Table 28. Rest of World Based Companies CGT CDMO Revenue Market Share (2018-2023)
    Table 29. World CGT CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Table 30. World CGT CDMO Market Size by Type (2018-2023) & (USD Million)
    Table 31. World CGT CDMO Market Size by Type (2024-2029) & (USD Million)
    Table 32. World CGT CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Table 33. World CGT CDMO Market Size by Application (2018-2023) & (USD Million)
    Table 34. World CGT CDMO Market Size by Application (2024-2029) & (USD Million)
    Table 35. Catalent Basic Information, Area Served and Competitors
    Table 36. Catalent Major Business
    Table 37. Catalent CGT CDMO Product and Services
    Table 38. Catalent CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 39. Catalent Recent Developments/Updates
    Table 40. Catalent Competitive Strengths & Weaknesses
    Table 41. Lonza Basic Information, Area Served and Competitors
    Table 42. Lonza Major Business
    Table 43. Lonza CGT CDMO Product and Services
    Table 44. Lonza CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 45. Lonza Recent Developments/Updates
    Table 46. Lonza Competitive Strengths & Weaknesses
    Table 47. Thermo Fisher Basic Information, Area Served and Competitors
    Table 48. Thermo Fisher Major Business
    Table 49. Thermo Fisher CGT CDMO Product and Services
    Table 50. Thermo Fisher CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 51. Thermo Fisher Recent Developments/Updates
    Table 52. Thermo Fisher Competitive Strengths & Weaknesses
    Table 53. ACG Biologics Basic Information, Area Served and Competitors
    Table 54. ACG Biologics Major Business
    Table 55. ACG Biologics CGT CDMO Product and Services
    Table 56. ACG Biologics CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 57. ACG Biologics Recent Developments/Updates
    Table 58. ACG Biologics Competitive Strengths & Weaknesses
    Table 59. WuXi AppTec Basic Information, Area Served and Competitors
    Table 60. WuXi AppTec Major Business
    Table 61. WuXi AppTec CGT CDMO Product and Services
    Table 62. WuXi AppTec CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 63. WuXi AppTec Recent Developments/Updates
    Table 64. WuXi AppTec Competitive Strengths & Weaknesses
    Table 65. Charles River Basic Information, Area Served and Competitors
    Table 66. Charles River Major Business
    Table 67. Charles River CGT CDMO Product and Services
    Table 68. Charles River CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 69. Charles River Recent Developments/Updates
    Table 70. Charles River Competitive Strengths & Weaknesses
    Table 71. Oxford Biomedica (OXB) Basic Information, Area Served and Competitors
    Table 72. Oxford Biomedica (OXB) Major Business
    Table 73. Oxford Biomedica (OXB) CGT CDMO Product and Services
    Table 74. Oxford Biomedica (OXB) CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 75. Oxford Biomedica (OXB) Recent Developments/Updates
    Table 76. Oxford Biomedica (OXB) Competitive Strengths & Weaknesses
    Table 77. Novartis Basic Information, Area Served and Competitors
    Table 78. Novartis Major Business
    Table 79. Novartis CGT CDMO Product and Services
    Table 80. Novartis CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 81. Novartis Recent Developments/Updates
    Table 82. Novartis Competitive Strengths & Weaknesses
    Table 83. OBiO Basic Information, Area Served and Competitors
    Table 84. OBiO Major Business
    Table 85. OBiO CGT CDMO Product and Services
    Table 86. OBiO CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 87. OBiO Recent Developments/Updates
    Table 88. OBiO Competitive Strengths & Weaknesses
    Table 89. GenScript Basic Information, Area Served and Competitors
    Table 90. GenScript Major Business
    Table 91. GenScript CGT CDMO Product and Services
    Table 92. GenScript CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 93. GenScript Recent Developments/Updates
    Table 94. GenScript Competitive Strengths & Weaknesses
    Table 95. Pharmaron Basic Information, Area Served and Competitors
    Table 96. Pharmaron Major Business
    Table 97. Pharmaron CGT CDMO Product and Services
    Table 98. Pharmaron CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 99. Pharmaron Recent Developments/Updates
    Table 100. Porton Basic Information, Area Served and Competitors
    Table 101. Porton Major Business
    Table 102. Porton CGT CDMO Product and Services
    Table 103. Porton CGT CDMO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
    Table 104. Global Key Players of CGT CDMO Upstream (Raw Materials)
    Table 105. CGT CDMO Typical Customers
List of Figure
    Figure 1. CGT CDMO Picture
    Figure 2. World CGT CDMO Total Market Size: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World CGT CDMO Total Market Size (2018-2029) & (USD Million)
    Figure 4. World CGT CDMO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
    Figure 5. World CGT CDMO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
    Figure 6. United States Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 7. China Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 8. Europe Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 9. Japan Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 10. South Korea Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 11. ASEAN Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 12. India Based Company CGT CDMO Revenue (2018-2029) & (USD Million)
    Figure 13. CGT CDMO Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 16. World CGT CDMO Consumption Value Market Share by Region (2018-2029)
    Figure 17. United States CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 18. China CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 20. Japan CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 21. South Korea CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 22. ASEAN CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 23. India CGT CDMO Consumption Value (2018-2029) & (USD Million)
    Figure 24. Producer Shipments of CGT CDMO by Player Revenue ($MM) and Market Share (%): 2022
    Figure 25. Global Four-firm Concentration Ratios (CR4) for CGT CDMO Markets in 2022
    Figure 26. Global Four-firm Concentration Ratios (CR8) for CGT CDMO Markets in 2022
    Figure 27. United States VS China: CGT CDMO Revenue Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: CGT CDMO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. World CGT CDMO Market Size by Type, (USD Million), 2018 & 2022 & 2029
    Figure 30. World CGT CDMO Market Size Market Share by Type in 2022
    Figure 31. Immune Cells
    Figure 32. Stem Cells
    Figure 33. Viral Vectors
    Figure 34. Plasmid DNA
    Figure 35. World CGT CDMO Market Size Market Share by Type (2018-2029)
    Figure 36. World CGT CDMO Market Size by Application, (USD Million), 2018 & 2022 & 2029
    Figure 37. World CGT CDMO Market Size Market Share by Application in 2022
    Figure 38. Pharmaceutical and Biotechnology Companies
    Figure 39. Research and Academic Institutions
    Figure 40. Hospital
    Figure 41. Others
    Figure 42. CGT CDMO Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Catalent
Lonza
Thermo Fisher
ACG Biologics
WuXi AppTec
Charles River
Oxford Biomedica (OXB)
Novartis
OBiO
GenScript
Pharmaron
Porton

Related Reports

Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Global CGT CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

date 16 Jul 2021

date Medical Care

The CGT CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Global CGT CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global CGT CDMO Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Medical Care

Global CGT CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Global CGT CDMO Market 2023 by Company, Regions, Type and Application, Forecast to 2029

date 02 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global CGT CDMO market size was valued at USD 4062.1 million in 2022 and is forecast to a readjusted size of USD 17320 million by 2029 with a CAGR of 23.0% during review period.

Global CGT CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global CGT CDMO Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global CGT CDMO market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Global CGT CDMO Supply, Demand and Key Producers, 2024-2030

Global CGT CDMO Supply, Demand and Key Producers, 2024-2030

date 19 Feb 2024

date Medical Care

The global CGT CDMO market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).

Product Tags

cgt cdmo

Organ Rejection Prophylaxis Treatment

Biologics Analytical Services

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>